Oct 11, 2016 12:02 pm UTC| Business
Reception to also feature update on ADXS-NEO: Personalizing Immunotherapy PRINCETON, N.J., Oct. 11, 2016 -- Advaxis, Inc. (NASDAQ:ADXS), a clinical stage biotechnology company developing cancer immunotherapies,...
Oct 11, 2016 12:02 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Oct. 11, 2016 -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a biopharmaceutical company developing meaningful therapies for patients with severe and life-threatening diseases that have been...
Oct 11, 2016 12:02 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Oct. 11, 2016 -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a biopharmaceutical company developing meaningful therapies for patients with severe and life-threatening diseases that have been...
Oct 11, 2016 12:02 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Oct. 11, 2016 -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a biopharmaceutical company developing meaningful therapies for patients with severe and life-threatening diseases that have been...
American Airlines Group Reports September Traffic
Oct 11, 2016 12:01 pm UTC| Business
FORT WORTH, Texas, Oct. 11, 2016 -- American Airlines Group (NASDAQ:AAL) today reported September and year-to-date 2016 traffic results. American Airlines Group’s total revenue passenger miles (RPMs) were 17.8...
American Airlines Group Reports September Traffic
Oct 11, 2016 12:01 pm UTC| Business
FORT WORTH, Texas, Oct. 11, 2016 -- American Airlines Group (NASDAQ:AAL) today reported September and year-to-date 2016 traffic results. American Airlines Group’s total revenue passenger miles (RPMs) were 17.8...
Oct 11, 2016 12:01 pm UTC| Business
First Ever Clinical Trial in Children Using a Targeted Chemotherapeutic Drug Released by Focused Ultrasound Expected to Commence in Q4 2016 Initiation of this NIH-funded Study follows the Recent Announcement of NIH’s...